Solo para uso de investigación
Todos los productos están destinados exclusivamente a la investigación de laboratorio y no para consumo humano ni animal. Al realizar la compra, el comprador acepta usar estos productos en cumplimiento con todas las leyes aplicables.
Melanotan I is a synthetic tridecapeptide composed of 13 amino acids. It was originally derived from the naturally occurring hormone alpha-melanocyte-stimulating hormone (α-MSH), modified at two positions to resist enzymatic breakdown. Since its characterization in the early 1980s, Melanotan I has been studied extensively in controlled experimental settings for its potential influence on melanocyte activity, receptor signaling, and pigmentary processes.
Sawyer T.K. et al. (1980).
The peptide was first synthesized by researchers at the University of Arizona investigating more stable analogs of α-MSH, which degrades within minutes in circulation. Early experiments focused on its ability to sustain melanocyte stimulation and prolonged biological activity in pigmentation models. Over time, studies broadened into receptor, photoprotective, and systemic systems, where Melanotan I (later developed as afamelanotide) consistently demonstrated properties of interest in the context of melanogenesis and biological resilience.
Hadley M.E. et al. (1998).
Melanotan I Structure
CAS #: 75921-69-6
Molecular Formula: C₇₈H₁₁₁N₂₁O₁₉
Molecular Weight: 1646.85 g/mol
PubChem ID: 16197727
Melanotan I has been studied in pigmentary, receptor, photoprotective, and systemic models, with reports of activity in melanin synthesis, melanocortin-receptor binding, UV-response modulation, and cellular signaling. Research also highlights signaling roles in preclinical systems, supporting cellular integrity and pathway dynamics. Key Areas of Research:
Pigmentary: Melanogenesis, eumelanin, melanocytes
Receptor: MC1R binding, melanocortin signaling, selectivity
Photoprotective: UV response, phototoxicity, skin
Systemic: Signaling, neuroprotection, pathway dynamics
Together, these findings suggest broad experimental utility for Melanotan I across multiple biological pathways. Its activity in pigmentary, receptor, photoprotective, and systemic models provides a foundation for exploring diverse aspects of molecular biology. By influencing processes such as melanin regulation, receptor activation, and molecular signaling, Melanotan I offers a versatile platform for research into pathway dynamics and systemic resilience within experimental settings.
Langendonk J.G. et al., New England Journal of Medicine, 2015
Referencias
Sawyer T.K. et al. (1980). A highly potent alpha-melanotropin, Nle4 D-Phe7 alpha-MSH, with ultralong biological activity, characterized and synthesized.
Hadley M.E. et al. (1998). Discovery and development of novel melanogenic drugs: Melanotan-I and -II.
The prolonged, calcium-dependent action of Nle4 D-Phe7 alpha-melanotropin on vertebrate chromatophores.
Behavioral effects of Nle4 D-Phe7 alpha-melanocyte-stimulating hormone in experimental models.
Nuestro proceso
Envíanos un mensaje, nuestro equipo dedicado está aquí para ayudar.
Preguntas Frecuentes
Todo lo que necesitas saber sobre nuestros productos y procesos.
What's the actual amount in each vial?
Are additional supplies needed?
How long does a vial last?
Does the product come with instructions?
What purity level is guaranteed?
¿Cómo debo almacenar estos productos?
